Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Aug 17, 2021 11:13am
142 Views
Post# 33716774

Frustrated !!!

Frustrated !!!Yep...I am starting to really question ...WTF...and for who's benefit....like why did they do the RS so early ...if they left it until they truly had the news as promised from the interviews ...the price had a chance to stay in tact and long investors would not lose confidence and dump... it only benefited the day flippers and shorts by giving them more room to play....b4 rs price was low but yes stayed in same spot cause we were at the lowest ..now flippers and shorts have plenty room to play or manipulate price low and the company gets no headache from tsxv trading regulations ...the lower they take it the only ones that will benefit are the ones to partake in the PP...wonder who that is...certainly not the long investors that lost faith and dumping ....here we are a month in no news as promised ...long investors turning on each other..and for those investors that were telling people nows the time to buy or they will miss out .... along with other supporting post only because they also believed that news was to follow...just made many investors not to take them serious and label them as bashers ....and now has making many longs questioning the integrity ....was the warrant chaos a deliberate tactic hmm ....hate thinking those thoughts ....I dunno will they have a partner and surprise us... do they really have the news ....or will it keep bouncing lower and we were all played....still hanging on by a thread...because I believe in Nitrix Oxide...not here to discredit other investors .. .just losing faith unless it comes in NR.. gltal
<< Previous
Bullboard Posts
Next >>